期刊
PEDIATRIC HEMATOLOGY AND ONCOLOGY
卷 27, 期 5, 页码 329-332出版社
INFORMA HEALTHCARE
DOI: 10.3109/08880011003758422
关键词
acute lymphoblastic leukemia; central nervous system relapse
The central nervous system (CNS) has long been recognized as a site, indeed a sanctuary, for leukemic cells. Although few (< 5%) patients with acute lymphoblastic leukemia (ALL) actually present with overt CNS leukemia, without prophylactic CNS-directed treatment, over 50% will develop CNS disease. However, with modern CNS prophylaxis, the incidence of CNS relapse has been reduced to 6% or less. Although great progress has been made, we continue to struggle with management of CNS leukemia. This commentary will address issues of CNS leukemia treatment at diagnosis and at relapse. Topics that will be addressed include (1) CNS 2 status at diagnosis-definition and treatment; (2) CNS leukemia at diagnosis-treatment with radiation therapy; (3) isolated relapse of leukemia in the CNS-treatment of early and late relapse; and (4) opportunities for future research in CNS relapse of ALL.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据